MarketCap
Facebook
X
Telegram
Country |
 Israel |
IPO year |
2018 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ CAPITAL |
Shares |
46.2 M |
Market Cap[1] |
$ 141 M |
EBITDA (LTM) |
$ -11.5 M |
P/E (LTM) |
12.0 |
P/S (LTM) |
3299.361929 |
EPS (LTM) |
0.25 |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Repare Therapeutics
RPTX
|
- | - | $ 112 M | Nasdaq Global Select Market |  Canada |
 |
Sesen Bio
SESN
|
- | 7.29 % | $ 127 M | Nasdaq Global Select Market |  USA |
 |
Windtree Therapeutics
WINT
|
- | - | $ 26.8 M | Nasdaq Global Select Market | USA |
 |
Trean Insurance Group
TIG
|
- | - | $ 316 M | Nasdaq Global Select Market | USA |
 |
SQZ Biotechnologies Company
SQZ
|
- | 57.95 % | $ 12.8 M | NYSE | USA |
 |
MEI Pharma
MEIP
|
- | 10.43 % | $ 20.5 M | Nasdaq Capital Market | USA |
 |
Palatin Technologies
PTN
|
- | - | $ 13 M | NYSE American | USA |
 |
Институт стволовых клеток человека
ISKJ
|
- | - | - | MOEX |  Russia |
 |
ММЦБ
GEMA
|
- | - | - | MOEX | Russia |
 |
Lyra Therapeutics
LYRA
|
- | - | $ 24.9 M | Nasdaq Global Market | USA |
 |
Завод ДИОД
DIOD
|
- | - | - | MOEX,SPB | Russia |
 |
Фармсинтез
LIFE
|
- | - | - | MOEX | Russia |
 |
ОЗОН Фармацевтика
OZPH
|
- | - | - | MOEX | Russia |
 |
Промомед
PRMD
|
- | - | - | MOEX | Russia |
 |
Brickell Biotech
BBI
|
- | -5.38 % | $ 6.06 M | Nasdaq Capital Market | USA |
 |
Applied Therapeutics
APLT
|
- | - | $ 8.42 M | Nasdaq Global Market,SPB | USA |
 |
ESSA Pharma
EPIX
|
- | - | $ 8.86 M | Nasdaq Capital Market | Canada |
 |
Generation Bio Co.
GBIO
|
- | - | $ 344 M | Nasdaq Global Select Market | USA |
 |
Clearside Biomedical
CLSD
|
- | - | $ 25.3 M | Nasdaq Global Market | USA |
 |
Merus N.V.
MRUS
|
- | - | $ 5.78 B | Nasdaq Global Select Market |  Niderland |
 |
RAPT Therapeutics
RAPT
|
- | - | $ 2.36 B | Nasdaq Global Select Market | USA |
 |
Exicure
XCUR
|
$ 1.01 | 1.3 % | $ 6.36 M | Nasdaq Capital Market | USA |
 |
Cellectis S.A.
CLLS
|
$ 0.97 | -2.17 % | $ 97.3 M | Nasdaq Global Market |  France |
 |
AbCellera Biologics
ABCL
|
$ 12.24 | 4.53 % | $ 3.66 B | Nasdaq Global Select Market | Canada |
 |
Arrowhead Pharmaceuticals
ARWR
|
$ 58.84 | -0.14 % | $ 7.87 B | Nasdaq Global Select Market,SPB | USA |
 |
BioMarin Pharmaceutical
BMRN
|
$ 55.21 | -2.18 % | $ 10.6 B | Nasdaq Global Select Market,SPB | USA |
 |
Celldex Therapeutics
CLDX
|
$ 29.37 | -3.04 % | $ 1.95 B | Nasdaq Global Select Market | USA |
 |
CollPlant Biotechnologies Ltd.
CLGN
|
$ 3.76 | -3.22 % | $ 45.9 M | Nasdaq Capital Market | Israel |
 |
Jaguar Health
JAGX
|
$ 2.28 | -13.31 % | $ 5.32 M | Nasdaq Capital Market | USA |
 |
Protalix BioTherapeutics
PLX
|
$ 2.57 | -2.65 % | $ 202 M | NYSE American | Israel |
 |
uniQure N.V.
QURE
|
$ 22.69 | -0.11 % | $ 1.3 B | Nasdaq Global Select Market | Niderland |
 |
Stoke Therapeutics
STOK
|
$ 25.68 | -3.49 % | $ 1.52 B | Nasdaq Global Select Market,SPB | USA |
 |
Xencor
XNCR
|
$ 25.16 | 0.88 % | $ 1.87 B | Nasdaq Global Select Market,SPB | USA |
 |
Annexon
ANNX
|
$ 3.86 | 0.78 % | $ 599 M | Nasdaq Global Select Market | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
$ 1.89 | -0.02 % | $ 3.11 M | NYSE American | Israel |
 |
Incyte Corporation
INCY
|
$ 113.44 | -2.72 % | $ 22.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Mesoblast Limited
MESO
|
$ 12.83 | 3.38 % | $ 15.5 B | Nasdaq Global Select Market |  Australia |
 |
MeiraGTx Holdings plc
MGTX
|
$ 9.86 | -1.1 % | $ 793 M | Nasdaq Global Select Market | USA |
 |
Vertex Pharmaceuticals Incorporated
VRTX
|
$ 524.52 | 1.92 % | $ 134 B | Nasdaq Global Select Market,SPB | USA |
 |
AbbVie
ABBV
|
$ 284.8 | -1.45 % | $ 504 B | NYSE,SPB | USA |
 |
Arcutis Biotherapeutics
ARQT
|
$ 31.87 | -2.89 % | $ 4.05 B | Nasdaq Global Select Market,SPB | USA |
 |
Altimmune
ALT
|
$ 2.23 | -3.04 % | $ 196 M | Nasdaq Global Market | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
$ 4.18 | -3.46 % | $ 801 M | Nasdaq Global Select Market | Canada |
 |
Axon Enterprise
AXON
|
$ 402.6 | 2.54 % | $ 31.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Oncternal Therapeutics
ONCT
|
- | -24.12 % | $ 1.56 M | Nasdaq Capital Market | USA |
 |
Black Diamond Therapeutics
BDTX
|
$ 2.08 | 0.48 % | $ 118 M | Nasdaq Global Select Market,SPB | USA |
 |
Burford Capital Limited
BUR
|
$ 3.05 | -0.65 % | $ 668 M | NYSE |  Britain |
 |
Catalyst Biosciences
CBIO
|
$ 13.17 | 0.77 % | $ 1.18 B | Nasdaq Capital Market | USA |
 |
Seagen
SGEN
|
- | - | $ 42.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Codexis
CDXS
|
$ 1.29 | 4.88 % | $ 112 M | Nasdaq Global Select Market | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.